Makena Interactions
There are 213 drugs known to interact with Makena (hydroxyprogesterone), along with 10 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 7 are major, 198 are moderate, and 8 are minor.
- View all 213 medications that may interact with Makena
- View Makena alcohol/food interactions (6)
- View Makena disease interactions (10)
Most frequently checked interactions
View interaction reports for Makena (hydroxyprogesterone) and the medicines listed below.
- acetaminophen
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Adempas (riociguat)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Aimovig (erenumab)
- Aranesp (darbepoetin alfa)
- Avastin (bevacizumab)
- Benlysta (belimumab)
- Botox (onabotulinumtoxinA)
- Copaxone (glatiramer)
- Euflexxa (sodium hyaluronate)
- folic acid
- Harvoni (ledipasvir / sofosbuvir)
- Keppra (levetiracetam)
- Lupron (leuprolide)
- Neulasta (pegfilgrastim)
- Ocrevus (ocrelizumab)
- Orencia (abatacept)
- Orthovisc (hyaluronan)
- Procrit (epoetin alfa)
- progesterone
- Prolia (denosumab)
- Remicade (infliximab)
- Rituxan (rituximab)
- Synvisc (hylan g-f 20)
- Tysabri (natalizumab)
- Xolair (omalizumab)
Makena alcohol/food interactions
There are 6 alcohol/food interactions with Makena (hydroxyprogesterone).
Makena disease interactions
There are 10 disease interactions with Makena (hydroxyprogesterone) which include:
- breast malignancy
- liver disease
- thromboembolism
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
QR code containing a link to this page
More about Makena (hydroxyprogesterone)
- Makena consumer information
- Compare alternatives
- Reviews (154)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: progestins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.